Showing results (661-670 of 3,703) with videos related to
Sort By:
Pageof 371
Pharmacology & Therapeutics|September 18, 2022
Therapeutics targeting the metastatic breast cancer bone microenvironmentClaire L Ihle, Sabrina J Wright-Hobart, Philip OwensPharmacology & Therapeutics|November 3, 2022
The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironmentYijie Wang, Xiong Liu, Weixiao Huang, et al.Pharmacology & Therapeutics|January 1, 1994
CCK antagonists: pharmacology and therapeutic interestJ G Wettstein, L Buéno, J L JunienPharmacology & Therapeutics|January 1, 1994
Oxidative stress: free radical production in neural degenerationM E Götz, G Künig, P Riederer, et al.Pharmacology & Therapeutics|November 1, 1993
Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approachW Priebe, R Perez-SolerPharmacology & Therapeutics|November 1, 1993
Are there limits to enzyme-inhibitor binding discrimination? Inferences from the behavior of nucleoside deaminasesR WolfendenPharmacology & Therapeutics|November 1, 1993
The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseasesY S Cho-Chung, T ClairPharmacology & Therapeutics|November 1, 1993
Molecular aspects of drug resistance in parasitic helminthsM H Roos, M S Kwa, J G Veenstra, et al.Pharmacology & Therapeutics|November 1, 1993
Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseasesJ Perie, I Riviere-Alric, C Blonski, et al.Pageof 371